• Zamawiaj do paczkomatu
  • Płać wygodnie
  • Obniżka

Comprehensive Dermatologic Drug Therapy

9781416024712
579,60 zł
521,64 zł Zniżka 57,96 zł Brutto
Najniższa cena w okresie 30 dni przed promocją: 521,64 zł
Ilość
Produkt niedostępny
Nakład wyczerpany (niedostępny u wydawcy)

  Dostawa

Wybierz Paczkomat Inpost, Orlen Paczkę, DPD, Pocztę, email (dla ebooków). Kliknij po więcej

  Płatność

Zapłać szybkim przelewem, kartą płatniczą lub za pobraniem. Kliknij po więcej szczegółów

  Zwroty

Jeżeli jesteś konsumentem możesz zwrócić towar w ciągu 14 dni*. Kliknij po więcej szczegółów

Opis
Safely and effectively prescribe todays full spectrum of topical, intralesional, and systemic drugs for dermatologic disorders! Dr. Steven E. Wolverton and a team of leading international experts explain what drugs to use, when to use them...and what to watch out for. This invaluable quick reference tool provides full-text explanations as well as at-a-glance summaries of key pharmacologic information, as well as treatment protocols and associated costs.
Szczegóły produktu
Saunders
31541
9781416024712
9781416024712

Opis

Rok wydania
2007
Numer wydania
2
Oprawa
miękka foliowana
Liczba stron
1104
Wymiary (mm)
246 x 189
Waga (g)
2091
  • I. Introduction

    1. Basic Principles of Pharmacology (Stephen E. Wolverton)
    2. Principles for Maximizing the Safety of Dermatologic Drug Therapy (Stephen E. Wolverton)
    3. Polymorphisms: Why Individual Drug Responses Vary (Benjamin N. Lockshin, Stephen E. Wolverton)

    II. Systemic Drugs for Infectious Diseases

    4. Systemic Antibacterial Agents (Neda Ashourian, Philip R. Cohen)
    5. Systemic Antifungal Agents (Aditya K. Gupta )
    6. Systemic Antiviral Agents (Y. Connie Chang, Vandana K. Madkan, Karan Sra, Daniel A. Carrasco, Patricia C. Lee, Stephen K. Tyring)

    III. Systemic Immunomodulatory and Antiproliferative Drugs

    7. Systemic Corticosteriods (Stephen E. Wolverton)
    8. Methotrexate (Jeffrey P. Callen, Carol L. Kulp-Shorten, Stephen E. Wolverton)
    9. Azathioprine (Stephanie Silos Badalamenti, Francisco A. Kerdel)
    10. Cytotoxic Agents (Clifford Perlis, Teddy D. Pan, Charles J. McDonald)
    11. Cyclosporine (Chai Sue Lee, John Y.M. Koo)
    12.Dapsone (Russell P. Hall III, Clinzo P. Mickle)
    13. Antimalarial Agents (Jeffrey P. Callen, Charles Camisa)
    14. Systemic Retinoids (Timothy J. Patton, Matthew J. Zirwas, Stephen E. Wolverton)
    15. Interferons (Brian Berman, Francisco Flores, Deborah Zel)l

    IV. Drugs Used in Conjunction with Ultraviolet or Visible Light

    16. PUVA Photochemotherapy (Warwick L. Morison)
    17. Extracorporeal Photochemotheraphy (Photopheresis) (Michael Girardi, Peter W. Heald)
    18. Photodynamic Therapy (Robert Bissonnette, Jaggi Rao)

    V. Biological Therapeutics

    19. Tumor Necrosis Factor (TNF) Inhibitors (Stephanie Mehlis, Kenneth B. Gordon)
    20. T-Cell Activation Inhibitors (Mark G. Lebwohl, Sapna Rao Palep)

    VI. Miscellaneous Systemic Drugs

    21. Antihistamines (Malcolm W. Greaves)
    22. Vasoactive and Antiplatelet Agents (Seth B. Forman, Algin B. Garrett)
    23. Antiandrogens and Androgen Inhibitors (Marty E. Sawaya)
    24. Psychotropic Agents (Chai Sue Lee, John Y.M. Koo)
    25. Intravenous Immunoglobulin Therapy (Kai Thomas, Anita Ruetter, Thomas A. Luger)
    26. Miscellaneous Systemic Drugs (Alfred L. Knable Jr., Loretta S. Davis)
    27. Drugs for the Skinternist (Michelle Pelle)

    VII. Topical Drugs for Infectious Diseases

    28. Topical Antibaterial Agents (Deborah J. Yang, Long T. Quan, Sylvia Hsu)
    29. Topical Antifungal Agents (Rhea M. Phillips, Theodore Rosen)
    30. Topical and Intralesional Antiviral Agents (Pranav B. Sheth)
    31. Antiparasitic Agents (Benjamin N. Lockshin)

    VIII. Topical Immunomodulatory and Antiproliferative Drugs

    32. Topical Corticosteroids (Michael R. Warner, Charles Camisa)
    33. Topical Retinoids (Naveed Sami, Julie C. Harper)
    34. Topical and Intralesional Chemotherapeutic Agents (Eunice Y. Tsai, Herschel S. Zackheim, Youn H. Kim)
    35. Topical Contact Allergens (Andrew N. Lin)
    36. Topical Calcineurin Inhibitors (Andrew N. Lin)
    37. Topical Vitamin D3 (Yolanda Rosi Helfrich, Dana L. Sachs, Sewon Kang)

    IX. Miscellaneous Topical Drugs

    38. Sunscreens (Stanley B. Levy)
    39. Therapeutic Shampoos (Robert T. Brodell, Kevin D. Cooper)
    40. Alpha-Hydroxy Acids (Amy B. Lewis, Helen Radoszycki)
    41. Agents Used for Treatment of Hyperkeratosis (Adam B. Hessel, Julio C. Cruz-Ramon, Dana Marshall Klinger, Andrew N. Lin)
    42. Cosmetic Therapy (Zoe Diana Draelos)
    43. Miscellaneous Topical Agents (Seth B. Forman)
    44. Insect Repellents (Mark S. Fradin)
    45. Systemic Adverse Effects Due To Topical Medications (Peter J. Aronson)
    46. Compounding in Dermatology (Linda F. McElhiney, Scott M. Ravis)

    X. Injectable and Mucosal Routes of Drug Administration

    47. Local Anesthetics (Michael J. Huether, David G. Brodland)
    48. Botulinum Toxin Injections (Christian Murray, Nowell Solish)
    49. Oral Mucosal Therapeutics (Ginat Wintermeyer Mirowski, Ernest Lee)

    XI. Major Adverse Effects from Systemic Drugs

    50. Hepatotoxicity of Dermatologic Drug Therapy (Stephen E. Wolverton)
    51. Hematologic Toxicity of Dermatologic Drug Therapy (Kathleen A. Remlinger)
    52. Drug Induced Malignancies (Stephen E. Wolverton)
    53. Dermatologic Drugs During Pregnancy and Lactation (Barbara R. Reed)
    54. Drug Interactions (Lori E. Shapiro, Neil H. Shear)
    55. Cutaneous Drug Reactions with Systemic Features (Sandra R. Knowles, Neil H. Shear)

    XII. Special Pharmacology and Therapeutic Topics

    56. Pharmacoeconomics (Marc Alan Darst, Jennifer Reddan)
    57. Informed Consent and Risk Management (Stephen E. Wolverton, Marshall B. Kapp )
    58. FDA Drug Approval Process (William H. Eaglstein)
    59. Pharmacovigilance: Verifying that Drugs Remain Safe (Joel M. Gelfand)
    60. Dermatologic Drug Therapy in Children (Christopher M. Bohyer)

    Index

    Appendices
Komentarze (0)